IVIG pre-admin code still valid, but use new J codes for product

Why This Topic Matters

IVIG billing involves both a service component and a drug product component, so changes in Medicare guidance can affect claim submission and reimbursement. Understanding the current code structure helps organizations avoid missed payment or incorrect reporting.

Article Sections

1. Medicare payment status for IVIG pre-administration services

   Discusses whether Medicare continues to recognize the pre-administration service in the current payment period and identifies the general source of the guidance. It also addresses the timing of the policy and its relationship to broader Medicare payment updates.

2. Billing requirements for IVIG claims

   Summarizes the claim components referenced for IVIG encounters and the limits described for reporting the pre-administration service. The section focuses on Medicare claims-processing guidance and related administrative instructions.

3. IVIG product code crosswalk

   Provides a crosswalk between older and newer product coding for IVIG drugs. The section distinguishes liquid and powder products and identifies the major code families involved in the transition.

4. Official resources

   Lists CMS reference materials cited in the article for further reading. These resources relate to transmittals and Medicare learning materials.